Author:
Rosell Daniel R,Zaluda Lauren C,McClure Margaret M,Perez-Rodriguez M Mercedes,Strike K Sloan,Barch Deanna M,Harvey Philip D,Girgis Ragy R,Hazlett Erin A,Mailman Richard B,Abi-Dargham Anissa,Lieberman Jeffrey A,Siever Larry J
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference48 articles.
1. Abi-Dargham A (2003). Probing cortical dopamine function in schizophrenia: what can D1 receptors tell us? World Psychiatry 2: 166–171.
2. Abi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y et al (2002). Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci 22: 3708–3719.
3. Arnsten AF, Cai JX, Murphy BL, Goldman-Rakic PS (1994). Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology (Berl) 116: 143–151.
4. Blanchet PJ, Fang J, Gillespie M, Sabounjian L, Locke KW, Gammans R et al (1998). Effects of the full dopamine D1 receptor agonist dihydrexidine in Parkinson's disease. Clin Neuropharmacol 21: 339–343.
5. Brewster WK, Nichols DE, Riggs RM, Mottola DM, Lovenberg TW, Lewis MH et al (1990). Trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist. J Med Chem 33: 1756–1764.
Cited by
85 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献